Obsidian’s mission is to develop and commercialize controllable cell and gene therapies

Obsidian’s mission is to develop and commercialize controllable cell and gene therapies that provide significant clinical benefits. The company envisions a future where patients receive precisely tailored treatments that maximize therapeutic outcomes while minimizing risks.Obsidian’s proprietary cytoDRiVE™ platform is designed to control the expression of proteins in living cells with high precision. This platform uses small molecules to regulate protein levels, ensuring that therapies can be fine−tuned for optimal safety and efficacy.The technology enables on−demand production of therapeutic proteins, which can be modulated to address the dynamic needs of different disease states.